Exploring physical activity level in patients with thoracic cancer: Implications for use as an outcome measure

Supportive Care in Cancer

Volumn 20, Issue 5, 2012, Pages 1113-1116

  Maddocks, Matthew ^a   Wilcock, Andrew ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Accelerometry; Cachexia; Function; Physical activity; Rehabilitation

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY ANALYSIS; TASK PERFORMANCE; THORAX CANCER; UNDIFFERENTIATED CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CACHEXIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; THORACIC NEOPLASMS; TIME FACTORS;

EID: 84863471546     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1393-z     Document Type: Article

References (14)

1. Laviano A, Meguid MM, Inui A, Muscaritoli M, Rossi-Fanelli F (2005) Therapy insight: cancer anorexia-cachexia syndrome- when all you can eat is yourself. Nat Clin Pract Oncol 2:158-165
2. Fearon K, Strasser F, Anker SD et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. doi:10-1016/S1470-2045(10)70218-7
3. Dodson S, Baracos VE, Jatoi A, Evans WJ, Cella D, Dalton JT, Steiner MS (2011) Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Ann Rev Med 62:265-279
4. Mantovani G, Madeddu C, Serpe R (2010) Improvement of physical activity as an alternative objective variable to measure treatment effects of anti-cachexia therapy in cancer patients. Curr Opin Supp Pall Care 4(4):259-265
5. Fearon KCH (2008) Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer 44:1124-1132
6. Maddocks M, Byrne A, Johnson CD, Wilson RH, Fearon KCH, Wilcock A (2009) Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility study. Supp Care Cancer 18:1539-1544
7. Grant PM, Ryan CG, Tigbe WW, Granat MH (2006) The validation of a novel activity monitor in the measurement of posture and motion during everyday activities. Br J Sports Med 40:992-997
8. Ryan CG, Grant PM, Tigbe WW, Granat MH (2006) The validity and reliability of a novel activity monitor as a measure of walking. Br J Sports Med 40:779-784
9. Maddocks M, Petrou A, Skipper L, Wilcock A (2010) Validity of three accelerometers during treadmill walking and motor vehicle travel. Br J Sports Med 44:606-608
10. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 5:649-655
11. Dupont WD, Plummer WD (1990) Power and sample size calculations: a review and computer program. Controlled Clinical Trials 11:116-128
12. Tudor-Locke C, Washington TL, Hart TL (2009) Expected values for steps/day in special populations. Prevent Med 49:3-11
13. Dahele M, Fearon KCH, Preston T, Skipworth RJE, Voss A, Wall L (2007) Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy. J Pain Symptom Manage 33:676-685
14. Dajczam E, Kasymjanova G, Kreisman H, Swinton N, Pepe C, Small D (2008) Should patient-rated performance status affect treatment decisions in advanced lung cancer? J Thorac Oncol 3:1133-1136